https://www.cnbc.com/2023/11/17/rsv-cdc-expedites-release-of-sanofi-astrazeneca-drug-amid-shortage.html
0
0
11/17/23 at 1:44pm
Organization
CNBC
Author
Annika Kim Constantino
38 words
0
Comments
The CDC's move to increase availability of Beyfortus, a monoclonal antibody from Sanofi and AstraZeneca, comes as RSV cases rise in some parts of the country.
You are the first to view
Create an account
or login to join the discussion